A 6-year-old boy from a tribal area in Chhattisgarh presents with severe photophobia, blepharospasm, and corneal haziness in both eyes. On examination, the cornea shows a central area of opacity with loss of lustre and a small ulcer at the 6 o'clock position. The anterior chamber is quiet. What is the most appropriate immediate management?

Explanation

## Clinical Diagnosis This child presents with **stage X3A xerophthalmia** (corneal ulceration with scarring risk) secondary to vitamin A deficiency. The presence of: - Corneal haziness (loss of lustre) - Central opacity - Corneal ulcer - Photophobia and blepharospasm All indicate **urgent corneal involvement** requiring immediate high-dose IV vitamin A. ## Management Hierarchy **High-Yield:** Corneal xerophthalmia (X2, X3A, X3B) is a **medical emergency**. IV vitamin A is mandatory to: 1. Halt corneal melting and necrosis 2. Promote epithelial healing 3. Prevent irreversible scarring and blindness ### Correct Answer: IV Vitamin A 100,000 IU **Key Point:** WHO protocol for **corneal xerophthalmia**: - **Immediately:** IV vitamin A 100,000 IU - **After 24 hours:** IV vitamin A 100,000 IU (repeat) - **After 14 days:** IV vitamin A 100,000 IU (third dose) **Clinical Pearl:** IV dosing is essential because: - Achieves **rapid, high plasma and tissue levels** - Corneal epithelium is avascular and depends on systemic delivery - Oral absorption may be impaired in malnourished children - Prevents progression to irreversible scarring (X3B) ## Adjunctive Measures **Tip:** Concurrent management includes: - **Topical antibiotics** (tetracycline or chloramphenicol ointment) to prevent secondary infection - **Protective patching** to reduce friction and photophobia - **Lubricating drops** (preservative-free) to maintain corneal moisture - **Avoid topical steroids** (risk of perforation in active ulceration) ## Pathophysiology of Corneal Involvement ```mermaid flowchart TD A[Vitamin A Deficiency]:::outcome --> B[Loss of goblet cells & mucin]:::outcome B --> C[Conjunctival xerosis]:::outcome C --> D{Progression?}:::decision D -->|No intervention| E[Corneal xerosis X2]:::urgent D -->|Oral therapy| F[Arrest at X1B]:::action E --> G[Corneal ulceration X3A]:::urgent G --> H[Corneal scarring X3B]:::urgent H --> I[Permanent blindness]:::urgent E -->|IV vitamin A| J[Epithelial healing]:::action G -->|IV vitamin A + topical Rx| K[Scar prevention]:::action ``` **Key Point:** Once corneal involvement occurs, **only IV vitamin A can prevent irreversible scarring**. Oral therapy is too slow and insufficient.